Literature DB >> 7909009

Slower heterosexual spread of HIV-2 than HIV-1.

P J Kanki1, K U Travers, S MBoup, C C Hsieh, R G Marlink, A Gueye-NDiaye, T Siby, I Thior, M Hernandez-Avila, J L Sankalé.   

Abstract

Because of the similar virological properties of HIV types 1 and 2, HIV-2 was assumed to be as infectious and capable of inducing AIDS as HIV-1. Seroepidemiological studies have shown significant rates of HIV-2 infection in West Africa, and surveys from other regions of the world indicate that the spread of HIV-2 infection continues. However the pathogenic potential of HIV-2 is considered to be lower than that of HIV-1. It is therefore important to understand the transmission properties of HIV-2 and its contribution to the AIDS pandemic. Since 1985, we have prospectively studied 1452 registered female prostitutes in Dakar, Senegal, with sequential evaluation of their antibody status to HIV-1 and HIV-2. During the study the overall incidence of HIV-1 and HIV-2 was the same (1.11 per 100 person-years of observation [pyo]). However, the annual incidence of HIV-1 increased substantially: there was a 1.4-fold increased risk per year and thus a 12-fold increase in risk over the entire study period. The incidence of HIV-2 remained stable, despite higher HIV-2 prevalence. In our population the heterosexual spread of HIV-2 is significantly slower than that of HIV-1, which strongly suggests differences in the viruses' infectivity potential.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Behavior; Biology; Cohort Analysis; Developing Countries; Diseases; French Speaking Africa; Heterosexuals; Hiv Infections--transmission; Immunity; Incidence; Measurement; Physiology; Prevalence; Prospective Studies; Prostitutes--women; Research Report; Senegal; Seroconversion; Sex Behavior; Studies; Viral Diseases; Western Africa

Mesh:

Year:  1994        PMID: 7909009     DOI: 10.1016/s0140-6736(94)90065-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  90 in total

Review 1.  Global impact of human immunodeficiency virus and AIDS.

Authors:  H D Gayle; G L Hill
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa.

Authors:  Natalie N Zheng; M Juliana McElrath; Papa Salif Sow; Andrew Mesher; Stephen E Hawes; Joshua Stern; Geoffrey S Gottlieb; Stephen C De Rosa; Nancy B Kiviat
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

3.  Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy.

Authors:  Eleonor Brandin; Rigmor Thorstensson; Sebastian Bonhoeffer; Jan Albert
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes.

Authors:  M A Montano; V A Novitsky; J T Blackard; N L Cho; D A Katzenstein; M Essex
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Genotypic resistance profiles of HIV-2-treated patients in West Africa.

Authors:  Charlotte Charpentier; Serge Eholié; Xavier Anglaret; Mélanie Bertine; Christine Rouzioux; Véronique Avettand-Fenoël; Eugène Messou; Albert Minga; Florence Damond; Jean-Christophe Plantier; François Dabis; Gilles Peytavin; Françoise Brun-Vézinet; Didier K Ekouevi
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

6.  HIV-1 incidence and HIV-1 associated mortality in a cohort of urban factory workers in Tanzania.

Authors:  M W Borgdorff; L R Barongo; A H Klokke; J N Newell; K P Senkoro; J P Velema; R M Gabone
Journal:  Genitourin Med       Date:  1995-08

7.  Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1.

Authors:  Geoffrey S Gottlieb
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

8.  Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.

Authors:  Geoffrey S Gottlieb; Ndeye Mery Dia Badiane; Stephen E Hawes; Louise Fortes; Macoumba Toure; Cheikh T Ndour; Alison K Starling; Fatou Traore; Fatima Sall; Kim G Wong; Stephen L Cherne; Donovan J Anderson; Stefanie A Dye; Robert A Smith; James I Mullins; Nancy B Kiviat; Papa Salif Sow
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

9.  Virological Characterization of Dual HIV-1/HIV-2 Seropositivity and Infections in Southern Ghana.

Authors:  Kwc Sagoe; Jaa Mingle; Rk Affram; S Britton; A Dzokoto; A Sonnerborg
Journal:  Ghana Med J       Date:  2008-03

10.  Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.

Authors:  Wim Jennes; Makhtar Camara; Tandakha Dièye; Souleymane Mboup; Luc Kestens
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.